Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.39 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TYR | P14679 | 2/20 | 0.37 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17739606 | 0.91 | GPR3 (0.57) | LMNAALDH1A1GPR3 | |
| SCHEMBL20219048 | 0.91 | LMNA (0.46) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL19135799 | 0.86 | MAPT (0.41) | LMNAALDH1A1 | |
| SCHEMBL13084741 | 0.83 | LMNA (0.48) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL4734151 | 0.82 | MAOA (0.54) | ALDH1A1GPR3 | |
| SCHEMBL12146999 | 0.79 | GPR3 (0.57) | ALDH1A1GPR3 | |
| SCHEMBL4730115 | 0.78 | MEN1 (0.41) | LMNAALDH1A1 | |
| SCHEMBL13087796 | 0.75 | LMNA (0.46) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL19135767 | 0.74 | ALDH1A1 (0.41) | ALDH1A1GAAHPGDHSD17B10 | |
| SCHEMBL24721334 | 0.74 | CHEK1 (0.57) | LMNAHPGDGFERHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10651399-B2 | Delayed fluorescence compound, and organic light emitting diode and display device using the same | LG DISPLAY CO., LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20180205023-A1 | Delayed Fluorescence Compound, and Organic Light Emitting Diode and Display Device Using the Same | LG DISPLAY CO., LTD. (KR) | 2018-07-19 | — | — | US | disclosed |
| US-9954186-B2 | Delayed fluorescence compound, and organic light emitting diode and display device using the same | LG DISPLAY CO., LTD. (KR) | 2018-04-24 | — | — | US | disclosed |
| US-9954186-B2 | Delayed fluorescence compound, and organic light emitting diode and display device using the same | LG DISPLAY CO., LTD. (KR) | 2018-04-24 | — | — | US | disclosed |
| US-9711735-B2 | Delayed fluorescence compound, and organic light emitting diode and display device using the same | LG DISPLAY CO., LTD. (KR) | 2017-07-18 | — | — | US | disclosed |
| US-9711735-B2 | Delayed fluorescence compound, and organic light emitting diode and display device using the same | LG DISPLAY CO., LTD. (KR) | 2017-07-18 | — | — | US | disclosed |
| US-20160133856-A1 | DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2016-05-12 | — | — | US | disclosed |
| US-9328097-B2 | Thermally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2016-05-03 | — | — | US | disclosed |
| US-20160111659-A1 | DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2016-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10651399-B2 | Delayed fluorescence compound, and organic light emitting diode and display device using the same | OCIAD1, OCIAD2, DRD2 | LMNA 3946/4885TRPA1 18/4885PTGS1 4446/4885 |
| US-20160111659-A1 | DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME | DRD1, CCND1, CCND2 | LMNA 635/4885TRPA1 17/4885PTGS1 3544/4885 |
| US-20160133856-A1 | DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME | OCIAD1, OCIAD2, OGFOD1 | LMNA 4362/4885TRPA1 17/4885PTGS1 3364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.